238 related articles for article (PubMed ID: 12165528)
21. Experimental induction of anergy to coccidioidin by antigens of Coccidioides immitis.
Ibrahim AB; Pappagianis D
Infect Immun; 1973 May; 7(5):786-94. PubMed ID: 4202961
[TBL] [Abstract][Full Text] [Related]
22. Dendritic cell-based vaccine against coccidioides infection.
Awasthi S
Ann N Y Acad Sci; 2007 Sep; 1111():269-74. PubMed ID: 17363430
[TBL] [Abstract][Full Text] [Related]
23. Interaction of human peripheral blood mononuclear cells with Coccidioides immitis arthroconidia.
Ampel NM; Galgiani JN
Cell Immunol; 1991 Mar; 133(1):253-62. PubMed ID: 1991329
[TBL] [Abstract][Full Text] [Related]
24. Host-Pathogen Interactions in Coccidioidomycosis: Prognostic Clues and Opportunities for Novel Therapies.
Krogstad P; Johnson R; Garcia-Lloret MI; Heidari A; Butte MJ
Clin Ther; 2019 Oct; 41(10):1939-1954.e1. PubMed ID: 31648806
[TBL] [Abstract][Full Text] [Related]
25. The complex immunology of human coccidioidomycosis.
Ampel NM
Ann N Y Acad Sci; 2007 Sep; 1111():245-58. PubMed ID: 17363432
[TBL] [Abstract][Full Text] [Related]
26. Coccidioidomycosis: host response and vaccine development.
Cox RA; Magee DM
Clin Microbiol Rev; 2004 Oct; 17(4):804-39, table of contents. PubMed ID: 15489350
[TBL] [Abstract][Full Text] [Related]
27. Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis.
Thompson GR; Lunetta JM; Johnson SM; Taylor S; Bays D; Cohen SH; Pappagianis D
Clin Infect Dis; 2011 Sep; 53(6):e20-4. PubMed ID: 21865185
[TBL] [Abstract][Full Text] [Related]
28. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
29. A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.
Hung CY; Ampel NM; Christian L; Seshan KR; Cole GT
Infect Immun; 2000 Feb; 68(2):584-93. PubMed ID: 10639421
[TBL] [Abstract][Full Text] [Related]
30. Immunotherapy of coccidioidomycosis.
Catanzaro A; Spitler L; Moser KM
J Clin Invest; 1974 Sep; 54(3):690-701. PubMed ID: 4604574
[TBL] [Abstract][Full Text] [Related]
31. Spherulin skin testing and histoplasmal and coccidioidal serology: lack of effect.
Deresinski SC; Levine HB; Kelly PC; Creasman RJ; Stevens DA
Am Rev Respir Dis; 1977 Dec; 116(6):1116-8. PubMed ID: 931185
[TBL] [Abstract][Full Text] [Related]
32. Flow cytometric assessment of human peripheral blood mononuclear cells in response to a coccidioidal antigen.
Ampel NM; Christian L
Med Mycol; 2000 Apr; 38(2):127-32. PubMed ID: 10817229
[TBL] [Abstract][Full Text] [Related]
33. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
34. Does the presence of mediastinal adenopathy confer a risk for disseminated infection in immunocompetent persons with pulmonary coccidioidomycosis?
Mayer AP; Morris MF; Panse PM; Ko MG; Files JA; Ruddy BE; Blair JE
Mycoses; 2013 Mar; 56(2):145-9. PubMed ID: 22809175
[TBL] [Abstract][Full Text] [Related]
35. In vitro production of tumor necrosis factor-alpha by adherent human peripheral blood mononuclear cells incubated with killed coccidioidal arthroconidia and spherules.
Ampel NM
Cell Immunol; 1994 Jan; 153(1):248-55. PubMed ID: 8287491
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.
Nguyen C; Barker BM; Hoover S; Nix DE; Ampel NM; Frelinger JA; Orbach MJ; Galgiani JN
Clin Microbiol Rev; 2013 Jul; 26(3):505-25. PubMed ID: 23824371
[TBL] [Abstract][Full Text] [Related]
37. Molecular and cellular mechanisms of protective immunity to coccidioidomycosis.
Kirkland TN; Raz E; Datta SK
Vaccine; 2006 Jan; 24(4):495-500. PubMed ID: 16181709
[TBL] [Abstract][Full Text] [Related]
38. Antigens of Coccidioides posadasii as an important tool for the immunodiagnosis of coccidioidomycosis.
de Aguiar Cordeiro R; Patoilo KR; Praciano SB; Medrano DJ; de Farias Marques FJ; Martins LM; Eulalio KD; de Deus Filho A; Cavalvanti Mdo A; Fechine MA; Brilhante RS; de Camargo ZP; Rocha MF; Sidrim JJ
Mycopathologia; 2013 Feb; 175(1-2):25-32. PubMed ID: 23242703
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary coccidioidomycosis.
Thompson GR
Semin Respir Crit Care Med; 2011 Dec; 32(6):754-63. PubMed ID: 22167403
[TBL] [Abstract][Full Text] [Related]
40. A review of innate and adaptive immunity to coccidioidomycosis.
Hung CY; Hsu AP; Holland SM; Fierer J
Med Mycol; 2019 Feb; 57(Supplement_1):S85-S92. PubMed ID: 30690602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
